Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Consolidated Net Income (2016 - 2025)

Vycor Medical has reported Consolidated Net Income over the past 16 years, most recently at -$307.0 for Q4 2025.

  • Quarterly Consolidated Net Income fell 490.38% to -$307.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2236.0 through Dec 2025, down 797.99% year-over-year, with the annual reading at -$2236.0 for FY2025, 797.99% down from the prior year.
  • Consolidated Net Income was -$307.0 for Q4 2025 at Vycor Medical, down from -$54.0 in the prior quarter.
  • Over five years, Consolidated Net Income peaked at -$47.0 in Q3 2024 and troughed at -$12172.0 in Q1 2021.
  • The 5-year median for Consolidated Net Income is -$731.0 (2022), against an average of -$2086.0.
  • Year-over-year, Consolidated Net Income skyrocketed 98.32% in 2024 and then plummeted 3626.53% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$958.0 in 2021, then increased by 29.23% to -$678.0 in 2022, then plummeted by 356.34% to -$3094.0 in 2023, then skyrocketed by 98.32% to -$52.0 in 2024, then crashed by 490.38% to -$307.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Consolidated Net Income are -$307.0 (Q4 2025), -$54.0 (Q3 2025), and -$1826.0 (Q2 2025).